Proceeding

Next Generation Sequencing (NGS) is a powerful platform that has enabled sequencing of thousands to millions of DNA molecules simultaneously. NGS allows for a large number of genes to be captured and sequenced in parallel, generating an enormous amount of data in a relatively short period of time at much lower cost “per gene”. Labs around the globe are using NGS to examine multiple disease associated alterations in parallel, resulting in a lower cost and faster turnaround time compared to single gene assays.NGS is revolutionizing multiple fields including personalized medicine, genetic diseases, and clinical diagnostics. IlluminaTruSight cardio panel provides a comprehensive workflow solution of 174 genes with known associations to 17 inherited cardiac conditions (ICC), including cardiomyopathies, arrhythmias, aortopathies, and more. The fast, easy workflow requires low sample input for simultaneous multigene analysis, saving time and money and providing a highly efficient solution to ICC genetic profiling.